{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T05:11:24Z","timestamp":1696569084155},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:00:00Z","timestamp":1353456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clncl Oncology"],"published-print":{"date-parts":[[2014,6]]},"abstract":"Abstract<\/jats:title>Aim<\/jats:title>To evaluate whether axillary ultrasound in combination with a biopsy (AUS<\/jats:styled-content> +\/\u2212 B<\/jats:styled-content>x) can predict the involvement of the non\u2010sentinel lymph nodes (NSLN<\/jats:styled-content>).<\/jats:p><\/jats:sec>Methods<\/jats:title>A review of all operable breast cancer patients who underwent AUS<\/jats:styled-content> +\/\u2212 B<\/jats:styled-content>x at our tertiary care center from J<\/jats:styled-content>anuary 2010 to A<\/jats:styled-content>pril 2011 was performed. All patients underwent AUS<\/jats:styled-content> as part of their pre\u2010operative evaluation. If the AUS<\/jats:styled-content> was suspicious, a fine\u2010needle aspiration or core\u2010needle biopsy was performed.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 88 patients included in our final analysis, 20 (23%) had positive AUS<\/jats:styled-content>\u2009+\u2009B<\/jats:styled-content>x and underwent axillary lymph node dissection (ALND<\/jats:styled-content>) at time of definitive surgery. In all, 68 of the 88 patients (77.3%) had negative AUS<\/jats:styled-content> +\/\u2212 B<\/jats:styled-content>x and underwent sentinel lymph node (SLN<\/jats:styled-content>) B<\/jats:styled-content>x at the time of definitive surgery. If the SLN B<\/jats:styled-content>x was negative, no further axillary surgery was performed and the NSLN<\/jats:styled-content> were assumed to be negative. If the SLN B<\/jats:styled-content>x was positive, ALND<\/jats:styled-content> was performed. Of the 68 patients, 62 (91%) had a negative NSLN<\/jats:styled-content>. Patients with positive AUS<\/jats:styled-content>\u2009+\u2009B<\/jats:styled-content>x carry a relative risk of 2.02 (P<\/jats:italic>\u2009<\u20090.00002) of having positive NSLN<\/jats:styled-content>.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>In operable breast cancer patients, a negative AUS<\/jats:styled-content>+\/\u2212 B<\/jats:styled-content>x may be a predictor of non\u2010involvement of the NSLN<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajco.12039","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T08:53:47Z","timestamp":1353488027000},"source":"Crossref","is-referenced-by-count":1,"title":["Negative axillary ultrasonography with biopsy may predict non\u2010involvement of the non\u2010sentinel lymph nodes in operable breast cancer patients"],"prefix":"10.1111","volume":"10","author":[{"given":"Muna","family":"Al Ayyan","sequence":"first","affiliation":[{"name":"Department of Surgery Tawam Hospital Al\u2010Ain United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omaima","family":"Bu Ali","sequence":"additional","affiliation":[{"name":"Department of Surgery Tawam Hospital Al\u2010Ain United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheikha","family":"Al Sharri","sequence":"additional","affiliation":[{"name":"Department of Surgery Tawam Hospital Al\u2010Ain United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kassis","sequence":"additional","affiliation":[{"name":"Department of Radiology Tawam Hospital Al\u2010Ain United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabir","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Oncology Tawam Hospital Al\u2010Ain United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Al\u2010Bashir","sequence":"additional","affiliation":[{"name":"Department of Surgery Tawam Hospital Al\u2010Ain United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"National Comprehensive Cancer Network.NCCN guidelines[cited 17 October 2012]. Available from:http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810013391401"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2560"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.90"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel node metastasis: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano AE","year":"2010","journal-title":"Ann Surg"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2008.06.006"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2007.11.015"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9095-8"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.01.024"},{"key":"e_1_2_7_11_1","first-page":"345","article-title":"Role of ultrasound\u2010guided fine needle cytology of axillary lymph nodes in breast carcinoma staging","volume":"108","author":"Brancato B","year":"2004","journal-title":"Radiol Med (Torino)"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9524-3"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2463061463"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10786"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2008.09.003"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2010.11.015"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1823-z"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9593-3"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-007-9009-3"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2009.02.001"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12039","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajco.12039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T16:45:33Z","timestamp":1696524333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.12039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,21]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1111\/ajco.12039"],"URL":"https:\/\/doi.org\/10.1111\/ajco.12039","archive":["Portico"],"relation":{},"ISSN":["1743-7555","1743-7563"],"issn-type":[{"value":"1743-7555","type":"print"},{"value":"1743-7563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,21]]}}}